Guest Editor of our ‘Next steps in the gene editing revolution’ edition, Sven Kili (Partner, Saisei Ventures), takes us on a guided tour of the gene editing landscape, highlighting recent milestones, approvals, emerging technologies, and ongoing challenges in the space. As breakthroughs in precision, personalization, and platform diversity begin to reshape what is possible for patients and developers alike, we reflect on where the field stands today and what it will take to realize the full potential of gene editing.
